Globavir Biosciences

Globavir Biosciences is a biopharmaceutical company creating novel therapeutics and diagnostic tool for treating infectious disease that is headquartered in Los Altos, California and was founded in 2011 by Shalabh Gupta and Vijay Pande. The company is focused on commercializing re-purposed drugs for controlling infectious diseases such as coronavirus, dengue fever, ebola, and ChikungunyaChikungunya. Their lead drug candidate is called GBV-006 and is a combination of two drugs approved by the FDA for affecting viral load and mortality of viral infections.

Globavir Biosciences is a biopharmaceutical company creating novel therapeutics and diagnostic tool for treating infectious disease that is headquartered in Los Altos, CaliforniaLos Altos, California and was founded in 2011 by Shalabh Gupta and Vijay Pande. The company is focused on commercializing re-purposed drugs for controlling infectious diseases such as coronavirus, dengue fever, ebola, and Chikungunya. Their lead drug candidate is called GBV-006 and is a combination of two drugs approved by the FDA for affecting viral load and mortality of viral infections.